Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
20%
Ph phase_1
1
20%
Ph phase_2
3
60%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 23 (60.0%)
Phase 31 (20.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_2

Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer

NCT00003692
completedphase_2

Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function

NCT00002624
completedphase_3

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

NCT00821860
completedphase_2

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

NCT00004033
completedphase_1

Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion

NCT00114205

Clinical Trials (5)

Showing 5 of 5 trials
NCT00003692Phase 2

Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer

Completed
NCT00002624Phase 2

Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function

Completed
NCT00821860Phase 3

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

Completed
NCT00004033Phase 2

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Completed
NCT00114205Phase 1

Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5